Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life |
| |
Affiliation: | 1. Department of Public Health and Policy, University of Liverpool, UK;2. Department of Biostatistics, University of Liverpool, UK;3. Department of Molecular and Clinical Pharmacology, University of Liverpool, UK;1. Department of Neurology, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates;2. Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates;1. Tokyo Medical and Dental University, Graduate School of Health Care Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan;2. Hara Clinic, Yokohama, Kanagawa, Japan;3. Onda Daini Hospital, Matsudo, Chiba, Japan;1. Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, Department of Neurology, Istanbul, Turkey;2. Bagcilar Education and Research Hospital, Department of Neurology, Istanbul, Turkey;3. Sisli Hamidiye Etfal Education and Research Hospital, Department of Algology, Istanbul, Turkey;4. Istanbul University, Faculty of Medicine, Department of Biostatistics, Istanbul, Turkey;1. Unité de Neurophysiologie (UNPN), Pôle de Psychiatrie “Solaris”, Centre Hospitalier Universitaire de Sainte-Marguerite, 270 Bd de Sainte-Marguerite, 13009 Marseille, France;2. Laboratoire de Neurosciences Cognitives (LNC), UMR CNRS 7291, Aix-Marseille Université, Marseille, France;3. Laboratoire Parole et Langage (UMR 7309), Aix-Marseille Université, Marseille, France;4. CIC-CPCET — Centre de Pharmacologie Clinique et Evaluations Thérapeutiques, Aix-Marseille Université, Marseille, France;5. Unité mixte INSERM Epilepsie et Cognition UMR 751, 27 Bd Jean Moulin, 13385 Marseille Cedex 05, France;6. Service de Neurophysiologie Clinique, Centre Hospitalo Universitaire de la Timone, 264, rue Saint-Pierre, 13005 Marseille, France;7. Hôpital Henri Gastaut, Etablissement hospitalier spécialisé dans le traitement des epilepsies, 300 Boulevard de Sainte-Marguerite, 13009 Marseille, France |
| |
Abstract: | Comorbidities are common in epilepsy, and their role in quality of life (QOL) is receiving increasing scrutiny. Considerable attention has been focused on the role of depression, the most common comorbidity, with rather less attention paid to its frequent concomitant, anxiety, and other conditions known to be at increased prevalence among people with epilepsy (PWE) when compared to the general population. In this paper, we report findings from a UK-based survey in which we examined self-reporting of two common comorbidities, anxiety and sleep problems, factors associated with them, and their role in QOL in people with and without epilepsy.Data were obtained via mailed questionnaires, supplemented by an internet survey, from PWE and age- and gender-matched controls. Based on self-reported symptoms, PWE were at higher risk of anxiety and sleep problems. Contributory factors for anxiety included poorer general health, worry about seizures, and self-reported antiepileptic drug (AED) side effects. Good social support emerged as protective for anxiety in PWE. Nighttime sleep problems were very common even in controls but were further elevated in PWE. Antiepileptic drug adverse events emerged as an important contributory factor for sleep problems. Trait anxiety emerged as significant for defining overall QOL, and its importance over state anxiety supports the notion of anxiety in PWE as a primarily premorbid condition. In contrast, sleep quality was not consistently predictive of QOL. Our study has important implications for clinical management, emphasizing the need for a holistic approach to address wider patient-reported problems as well as any epilepsy-specific ones. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|